Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare
    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The Global Cell Culture Market is valued at USD 11,210.7 million in 2015 and growing at a CAGR of over 10% between 2017 and 2025.

    Key players: Overview of market leaders in Cell Culture market by top manufacturers/players, with Cell Culture revenue (Million USD) and market share for each manufacturer/player; the top players including Sartorius AG, Thermo Fisher Scientific, Merck KGaA, Corning Incorporation, Sigma - Aldrich Co. LLC, Promocell GmbH, GE Healthcare, Eppendorf AG, Becton, Dickinson & Company and VWR International, LLC.

    Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55941

    Increasing R&D activities of healthcare, biological, and stem cell applications has enhanced the demand of molecular biological activities which is further projected to persist a vibrant aspect for market growth. Cell culture technology includes several complications including raw material supply and fully traceable botanical extracts. Also, growing attention on certifying regulatory compliances associated with environmental sustainability can impede the efficacy of the technology.

    Additionally, affluence from various applications such as genetic engineering, research model systems, and continuous research related to cellular functions and stem cell research is also expected to drive the cell culture process globally. Few other factors spurring the growth includes rise in life sciences research, cell based technology advancement, cumulative cell based production, and mounting demand of cell based therapies.

    Rising growth in the number of regulatory approvals for cell culture-based vaccines and increasing funding for cell-based research will also influenced the market positively. Furthermore, growing application of single-use technologies and rising demand for mAbs are few factor projected to spur the market growth. Though, extensive cost involvement in cell culture research, lack of awareness for diagnosis technologies, and high contamination risks may hinder the market growth. Furthermore, optimization & handling of cell-based protocol in vitro studies will defies the market growth.

    Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55941/ (Priced at USD 4199)

    The report includes -
    Segmentation: On the basis of product, this report displays the revenue, market share and growth rate of each type, primarily split into
    • Consumables
    • Instrument

    On the basis on the applications, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
    • Biopharmaceuticals
    • Drug Development
    • Cancer Research
    • Culture Systems
    • Gene Therapy
    • Toxicity Testing
    • Tissue Culture & Engineering
    • Vaccine Production

    Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55941

    Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Million USD), market share and growth rate of Cell Culture for these regions, from 2015 to 2025 (forecast)
    North America: U.S., Rest of North America
    Europe: Germany, France, UK, rest of Europe
    Asia Pacific: China, Japan, India and Rest of Asia Pacific
    Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
    Latin America: Brazil and Rest of Latin America


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) Global Medical Device Connectivity market was valued at USD 443.91 Million in 2016 and is projected to reach USD 3260.06 Million by 2025, growing at a CAGR of 24.8% from 2016 to 2025.

    Medical Device connectivity is a broad term which covers Artificial Intelligence and Big Data Analytics too. With increasing wireless connectivity in almost every domain, the demand for wireless tools in the medical sector is increasing at a tremendous rate. Modernization of hospitals and old age homes involve major applications of medical device connectivity with respect to patient monitoring and dosage monitoring. Also, alerts and emergency alarms comprise significant components functioning as connected devices. Interconnectivity in medical premises is supported by Govt. regulatory framework making it more widespread.

    Download Sample Copy@http://bit.ly/2x6vCL5

    Certain factors such as penetrated applications of Electronic Health Records and Stringency in Govt. regulations regarding patient safety and care in medical centers are expected to drive the market during the forecast period. However, there are certain restraints that can cause a slowdown in the market expansion, such as unaccepting medical professionals towards medical device digitalization and a dearth of medical IT professionals to make the practice more convenient.

    The major players in the market are as follows:

    GE Healthcare
    Qualcomm Inc.
    Cerner Corporation
    Nanthealth, Inc.
    Koninklijke Philips N.V.
    Medtronic PLC
    Cisco Systems, Inc.
    Infosys Limited
    Digi International Inc.
    Lantronix, Inc.
    Bernoulli Enterprise, Inc

    Ask for Discount @ http://bit.ly/2MobEAM

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The global Hearing Aids Market was valued at USD 6.34 billion in 2016 and is projected to reach USD 11.53 billion by 2025, growing at a CAGR of 6.87% from 2017 to 2025.

    A Hearing Aid device is of immense utilization for older age groups who lose out on their ability to listen. The major driver for the market is thus growing the geriatric population. Another factor which drives the growth of the market is modern developments associated with hearing aid technologies causing the end users to adopt the devices.

    Download Sample Copy@http://bit.ly/2Mo9EsC

    The cost associated with high tech devices could restrain some of the users to utilize the devices. Besides, lack of penetration of these devices in some of the under-developed markets has also restricted its growth.

    The major players in the market are as follows:

    Sonova
    William Demant
    Gn Store Nord
    Cochlear
    Sivantos
    Starkey
    Widex
    Med-El
    Zounds Hearing
    Sebotek Hearing Systems
    Audina Hearing Instruments
    Rion
    Horentek
    Microson
    Arphi Electronics

    Ask for Discount @ http://bit.ly/2OdqRXb

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) At Verified Market Intelligence, we provide a market study that encompasses both qualitative and quantitative assessments of the latest trends for the market segmentations classified by our analysts. According to Verified Market Intelligence, the Global Pemetrexed Diacid Market was valued at USD 3.83 billion in 2017 and is projected to reach USD 6.41 billion by 2025, growing at a CAGR of 6.7% from 2018 to 2025.

    With growing pre-disposition towards cancer, people are more alert and looking for solutions that can help cure cancer. Pemetrexed diacid is one such drug approved by the Food and Drug Administration (FDA) to be used in the treatment of cancer in chemotherapy and immunotherapy. It can be used as a supplement or in combination therapy with carboplatin or cisplatin. This drug flourished the pharmaceutical and healthcare industry.

    Download Sample Copy@http://bit.ly/2x6rRVZ

    The Global Pemetrexed Diacid Market is segmented on the basis of consumption type, cancer type, therapeutic modalities, and geography. Increased reported cases of lung cancer and growing consumption of chemotherapy have accelerated the global pemetrexed diacid market. Apart from this, Production of generics due to loss of patent might hamper the overall growth rate.

    The “Global Pemetrexed Diacid Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Eli Lilly and Company, Fresenius Kabi, Teva Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories, Abbott Laboratories, Cadila Healthcare Ltd, Accord Healthcare Inc, QILU Pharma Co Ltd, Accure Labs Pvt. Ltd, Pfizer Inc. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

    As a part of market estimation, the study also comprises a list of tables and figures for the “Global Pemetrexed Diacid Market” which focuses on a constructive knowledge essential for the companies or individuals interested in the market study report. As a part of market segmentation, our study exhibits a market analysis on the basis of type, industry application and geography.

    On the basis of type, the Global Pemetrexed Diacid Market can be categorized into three sections; by consumption type, cancer type and therapeutic modality. This market study analyses the industry for Global Pemetrexed Diacid Market based on these divisions. Pemetrexed Diacid Market consumption is divided into supplements and cancer type. The industry is then sectioned by cancer type which includes lung cancer, liver cancer, colorectal cancer, stomach cancer, breast cancer and others. In terms of geography, Asia Pacific accounts for the fastest growing market due to the presence of numerous developing countries in this region along with their emerging markets. The Chinese market has a major share in this region.

    Ask for Discount @ http://bit.ly/2OgMoP0

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) At Verified Market Intelligence, we provide a market study that encompasses both qualitative and quantitative assessments of the latest trends for the market segmentations classified by our analysts. According to Verified Market Intelligence, the Global Mini C-Arm Market was valued at USD 749.8 million in 2017 and is projected to reach USD 981.7 million by 2025, growing at a CAGR of 3.4% from 2018 to 2025.

    Mini C Arm is a device used in intensifying X-ray produced images. Mini C-Arm connects the source to the detector and helps in image scanning intensity of the images. Mini C-Arm can be remotely accessed due to its compact size and has been booming in the healthcare and pharmaceutical industry. It is used in sports clinics, podiatric and orthopedic imaging.

    Download Sample Copy@http://bit.ly/2x9uJRU

    The advancement in medical devices and equipment along with its popularity in the old aged population. This characteristic has been driving the global mini C-arm market. Apart from this, the complex nature of medical devices might hamper the growth of the overall market.

    The “Global Mini C-Arm Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as GE Healthcare, Philips Healthcare, Siemens Healthineers, Hologic, FM Control, Perlong Medical, Toshiba Medical Systems Corporation, OrthoScan, Intermedical, Ecotron. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis

    As a part of market estimation, the study also comprises a list of tables and figures for the “Global Mini C-Arm Market” which focuses on a constructive knowledge essential for the companies or individuals interested in the market study report. As a part of market segmentation, our study exhibits a market analysis on the basis of type, industry application and geography.

    On the basis of type, the Global Mini C-Arm Market can be categorized into two sections; product and end user. This market study analyses the industry for Mini C-Arm Market based on these divisions. The Mini C-Arm products are divided into Mini C-Arm with Pulsed Fluoroscopy and Mini C-Arm with Continuous Fluoroscopy. The industry is then sectioned by the end user which includes hospitals and clinics. In terms of geography, Asia Pacific accounts for the fastest growing market due to the presence of numerous developing countries in this region along with their emerging markets. The Chinese market has a major share in this region.

    Ask for Discount @ http://bit.ly/2xaCxmx

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) According to Verified Market Intelligence, the global medical image analysis software market is valued at USD 2.31 billion in 2016 and is projected to reach USD 4.63 billion by 2025, growing at a CAGR of 8% from 2017 to 2025.

    Medical imaging is a science which solves and analyses the medical conditions of the patients on the basis of digital image analysis techniques. .It’s basically a technology which creates the visual representation of human interior body which reveals the internal structures of the organs as well as the function of some organs or tissues which helps in diagnosis and treatment of the diseases. There are various medical imaging techniques such as magnetic resonance imaging (MRI) and computed tomography (CT) scan which are used for diagnosis and followed up treatment of different diseases.

    Download Sample Copy@http://bit.ly/2MmNjvv

    Growth of Computer Aided technology in healthcare and increased efficiency of technological systems and software has been driving the Medical Image Analysis Software Market. While security risks of data stored in systems along with high installation cost and maintenance might hinder the overall growth rate of the global medical image analysis software.

    The major players in the market are as follows:

    Fujitsu Ltd.
    3M cogent, Inc.
    DXC Technology company
    NEC Corporation
    Lumidigm
    Morpho
    Imprivata, Inc.
    Suprema, Inc.
    Bio-key International, Inc.
    Zkteco, Inc.

    Ask for Discount @ http://bit.ly/2xc4UAI

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) According to Verified Market Intelligence, the global healthcare BPO market is valued at USD 167.66 billion in 2016 and is projected to reach USD 413.84 billion by 2025, growing at a CAGR of 10.01% from 2017 to 2025.

    Healthcare BPO services is mainly responsible for providing customized solutions in order to remove the complexity in the tedious tasks. Healthcare BPO services focus on enhancing the resource distribution and financial performance along with increasing the effectiveness of the providers. Medical billing & collection of medical billing, medical data entry, medical records indexing, medical coding, medical claims processing etc. are the services provided by the healthcare BPO. It mainly emphasis on enhancing the satisfaction of the patients with the reduced administration costs.

    Download Sample Copy@http://bit.ly/2MmYG6F

    Increased cases of diseases and infections resulting in increased healthcare demands has been driving the global healthcare BPO market. Apart from this, lack of technological experts and expensive methodologies acts a potential restraints for the global healthcare BPO market

    The major players in the market are as follows:

    Accenture
    Cognizant
    Firstsource Solutions
    Genpact
    IBM
    Infosys
    Lonza
    Omega Healthcare
    TATA
    XEROX
    WNS Holdings
    Invensis Technologies

    Ask for Discount @ http://bit.ly/2Moezd4

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) According to Verified Market Intelligence, the global patient engagement solutions market was valued at USD 8.12 billion in 2016 and is projected to reach USD 28.55 billion by 2025, growing at a CAGR of 12.8% from 2017 to 2025.

    Patient Engagement is a strategy used by the healthcare system in which the provider and patients work together and patients are engaged in their own health in order to achieve better outcomes. Maintenance of all the data regarding the patient’s latest health reports, dosage, medicines is done which is easily accessible by the patients. This software supports the patient to manage their own healthcare and the consultant to provide suitable solutions.

    Download Sample Copy@http://bit.ly/2x71miV

    Increased care from the government towards patients and personal medication along with increasing usage of phones in Healthcare and consultancy has been driving the global patient engagement solutions market. Also, increased stakeholder investment and rising partnerships between stakeholders has influenced the overall market. Apart from this, lack of health literacy and IT professionals can hinder the growth of the global patient engagement solutions market.

    The major players in the market are as follows:

    Mckesson
    Allscripts
    IBM
    Athenahealth
    Orion Health
    Cerner
    Getwellnetwork
    LincorSolutions
    Yourcareuniverse
    Welvu
    Get Real health
    Oneview Healthcare

    Ask for Discount @ http://bit.ly/2xaCvep

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) According to Verified Market Intelligence, the global digital pathology market was valued at USD 383.1 million in 2016 and is projected to reach USD 1,045.41 Million by 2025, growing at a CAGR of 11.8% from 2016 to 2025.

    Digital pathology also referred as virtual microscopy is defined as an image- based environment in which digital slides are created from the glass slides using a scanning device to generate a high resolution digital image. These images provide the pathological information which can be viewed, shared, managed and analyzed on computers. Recent advances in Whole-Slide Imaging has been used to diagnose diseases such as cancer and other important diseases. Digital pathology is gaining momentum globally and is proven to be an essential technology used across pharmaceuticals and health sectors, education and research organizations. In order to reduce the costs associated with drug trials and risks and to get precise results, medical centers are investing in the market.

    Download Sample Copy@http://bit.ly/2x9std9

    Increased usage of digital pathology and efforts to enhance lab ethics and quality has been driving the global digital pathology market. On the other hand, high implementation cost and lack of IT specified guidelines acts a potential restraints for the overall market at a global level.

    The major players in the market are as follows:

    Leica Biosystems
    Ventana Medical Systems
    Hamamatsu Photonics
    3DHISTECH
    Koninklijke Philips
    Apollo Enterprise Imaging
    XIFIN
    Huron Digital Pathology
    Visiopharm
    Corista
    Indica Labs
    Objective Pathology Services

    Ask for Discount @ http://bit.ly/2OgbnSz

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) According to Verified Market Intelligence, the global behavioral/mental health software market was valued at USD 981.32 million in 2016 and is projected to reach USD 3.43 billion by 2025, growing at a CAGR of 14.4% from 2017 to 2025.

    Mental health software (MHS) is a healthcare management software that allows the psychologists, counselors and mental health specialists to understand the mental and behavioral patterns of the patient/s and suggesting them a personalized treatment plan accordingly to deal against addiction stress, anxiety, depression etc. on their personal level. It is capable of storage, retrieval, and sharing of pharmacological, radiological and laboratory data observations.

    Download Sample Copy@http://bit.ly/2MmMZgh

    The growing demand for psychological help along with growing usage of Bhs and implementation of MHS (software) in health organizations has been driving the global behavioral/mental health software market. On the other hand, lack of IT specialists in the field and issues of data confidentiality hinders the growth of the global behavioral/mental health software market.

    The major players in the market are as follows:

    Cerner
    Netsmart
    Mindlinc
    Nextgen Healthcare
    Valant
    Welligent
    The Echo Group
    Meditab
    Kareo
    Qualifacts

    Ask for Discount @ http://bit.ly/2CNbK5w

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) At Verified Market Intelligence, we provide a market study that encompasses both qualitative and quantitative assessments of the latest trends for the market segmentations classified by our analysts. According to our research team, the Global Orthopedic Braces and Supports Market USD 3.11 billion in 2016 and is projected to reach USD 4.95 billion by 2025, growing at a CAGR of 5.31% from 2017 to 2025. Our research study mainly includes an in-depth study of the market which includes major drivers, restraints, opportunities, and challenges faced in the market along with the latest industrial trends.

    Download Sample Copy@http://bit.ly/2Moe7LU

    Orthopedic braces and supports are used by the majority of the geriatric population as an aid. In addition, with the increase in popularity of sports and athletic activities, the number of severe injuries has also increased causing an increase in the demand for the orthopedic braces and support material. However, availability of other low-cost alternatives has restrained the market to grow.

    The “(otc) Orthopedic Braces Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Breg, Inc, Össur Hf, Bauerfeind AG, BSN Medical, DJO Finance LLC, 3M Company, Otto Bock Healthcare, Deroyal Industries, Inc, Medi GmbH & Co. KG, Thuasne Group, Alcare Co., Ltd, Zimmer Biomet Holdings, Inc, Trulife, Remington Products Company, Bird & Cronin. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

    On the basis of type, the Global Orthopedic Braces and Supports Market can be categorized by primary types; Soft & Elastic Braces and Supports, Hinged Braces and Supports and Hard & Rigid Braces and Supports. This market study also features the market analytics based on the products which include Lower Extremity Braces and Upper Extremity Braces and Supports.

    In terms of geography, North America is the largest shareholder of orthopedic braces and supports and the Asia Pacific is expected to be the fastest emerging regional market for orthopedic braces and supports.

    Ask for Discount @ http://bit.ly/2OfXnYV

    About Us:
    Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

    Contact Information:

    Verified Market Research
    Contact Person: Ankush
    Tel: +1650781 4080
    Email us: sales@verifiedmarketresearch.com



    Amaan Kazi
    +1 (650) 781 4080
    amaankazi@verifiedmarketresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, September 15, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Life Science Microscopy Devices Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-life-science-microscopy-devices-sales-market-report-2018

    Global Life Science Microscopy Devices Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Olympus
    • Nikon
    • Carl Zeiss Microscopy
    • Bruker
    • Fei Company
    • Joel Ltd
    • Cameca
    • Hitachi High-Technologies
    • Leica Microsystems
    • Nt-Mdt Company
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/933517

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Optical Microscopes
    • Electron Microscopes
    • Scanning Probe Microscopes
    • Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Life Science Microscopy Devices Sales for each application, including
    • Cell Biology
    • Neuroscience
    • Pharmacology & Toxicology
    • Clinical / Pathology
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/933517


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 18, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of global Clinical Trial Management System market for 2018-2023.
    A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadlines and milestones.
    By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2018. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.
    Over the next five years, this report projects that Clinical Trial Management System will register a 12.6% CAGR in terms of revenue, reach US$ 1170 million by 2023, from US$ 570 million in 2017.
    This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Management System market by product type, application, key manufacturers and key regions.
    To calculate the market size, this report considers value and volume generated from the sales of the following segments:
    Segmentation by product type:
    Enterprise CTMS
    Site CTMS
    Segmentation by application:
    Pharma & Biopharmaceutical
    Medical Device
    Delivery Mode (Web Hosted, On-premise, Cloud-based)
    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries
    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Oracle
    Medidata Solutions
    Parexel
    Bioclinica
    Bio-Optronics
    IBM
    Datatrak
    Veeva Systems
    DSG
    Mastercontrol
    ERT
    Forte Research Systems
    Mednet Solutions
    Arisglobal
    DZS Software Solutions
    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
    Research objectives
    To study and analyze the global Clinical Trial Management System consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Clinical Trial Management System market by identifying its various subsegments.
    Focuses on the key global Clinical Trial Management System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Clinical Trial Management System with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Clinical Trial Management System submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

    To get Free Sample or to Buy this report at discounted price visit: https://www.nxtgenreports.com/market-research-reports/2018-2023-global-clinical-trial-management-system

    If you have any special requirements, kindly Contact Us and we will offer you the report as you want.

    About NxtGen Reports: NxtGen Reports delivers strategic market research reports, industry analysis, business research and forecasts on product, services and companies. We understand the need of our customers and keep our market research reports up to date. Our reports are very well organized enabling our customers to identify and get access easily. We also offer customized discounts based on your expectations.

    Contact Information:
    Madhuri Vetal
    NxtGen Reports
    Email: sales@nxtgenreports.com
    Phone: +918551022388
    More Report at: https://www.nxtgenreports.com/market-research-reports



    Madhuri Vetal
    +918551022388
    sales@nxtgenreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The Global Orthopedic Devices market was valued at USD 30.4 Billion in 2016, and is projected to reach USD 43.6 billion by 2025, growing at a CAGR of 4% over the forecast period.

    Key players: Overview of market leaders in orthopedic devices market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including DePuy Synthes, Medtronic Spinal, Medacta, Zimmer Biomet, NuVasive, MicroPort Scientific Corporation (Wright Medical Group), Smith & Nephew, Stryker, DJO Global, Globus Medical and ConforMIS.

    Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55953

    An orthopedic implant is a medical device utilized over a missing bone or joint to provide support to the damaged bone. Stainless steel and titanium alloys are used for the strength of devices and a plastic coating acts as an artificial cartilage. Increasing prevalence of osteoporosis, growing geriatric population base with developing technological advancements are expected to major drivers behind the industry growth over the forecast period.

    Increasing efficiency of devices and persistent innovation in the design of equipment, growing prevalence of diabetes and obesity and rising trend of alcohol consumption and smoking are projected to propel the market growth over the forecast period. Furthermore, gene therapy, 3D printing, tissue engineering, robot-assisted surgical procedures and smart implants have the efficiency to provide preventive and not curative measures which is also anticipated to boost the development of cost-effective devices in the industry.

    Increasing incidences of sports injuries and road accidents and the growing demand for minimally invasive surgical procedures is anticipated to positively impact the global industry revenue. The Asia Pacific region holds exemplary growth potential for orthopedic device manufacturers, owing to high population number and around 50% of world’s geriatric population base.

    Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55953/ (Priced at USD 4199)

    The report includes -
    Segmentation: Based on type segment, the report segregates the segment and delivers the revenue, growth rate, and market share, of each type,
    • Upper Extremity Devices
    o Shoulder
    o Elbow Radius
    o Others
    • Lower Extremity Devices
    o Hip
    o Knee
    o Foot
    o Ankle
    o Others
    • Spine Orthopedic Devices
    o Artificial Discs
    o Fixation Screws
    o Fixation Nail/Rod
    o Fixation Plates
    o Fixation Wires
    • Arthroscopic Devices
    • Orthobiologics
    o Bone Cement
    o Bone Graft Substitute
    o Bone Growth Factors
    o Others
    • Braces & Support Devices

    Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55953

    Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of orthopedic devices for these regions, from 2015 to 2025 (forecast)
    • North America: U.S., Rest of North America
    • Europe: Germany, France, UK, rest of Europe
    • Asia Pacific: China, Japan, India and Rest of Asia Pacific
    • Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
    • Latin America: Brazil and Rest of Latin America


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The Global Point of Care Diagnostic market was valued at USD 15.4 Billion in 2015, and is projected to reach USD 28.7 billion by 2025, growing at a CAGR of 5% over the forecast period.

    Key players: Overview of market leaders in POC Diagnotics market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including include Abbott Laboratories, bioMérieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.), Abaxis, Siemens, EKF Diagnostics, Danaher, Instrumentation Laboratory, Healthineers, Nova Biomedical, Quidel Corporation, Trinity Biotech, Chembio Diagnostics, Sekisui Diagnostics LLC, Trividia Health, Inc., OraSure Technologies Inc, Becton Dickinson & Company (BD), and Johnson & Johnson Services, Inc.

    Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55955

    Emerging technological advancements in biosensors, smartphones, wearable devices and lab-on-a-chip are transforming the point of care diagnostic market. The POC diagnostics industry has been expected to be a part of paradigm shift from curative medicine to predictive, preemptive and personalized medicine. POC diagnostic tests are either antibody-based or microbial particle-based, assisting in decreasing the interval between diagnosis and treatment of a disease.

    High prevalence of infectious diseases in emerging nations, increasing preferences for home healthcare option, and rising incidences of target diseases across the globe are few factors gaining the traction of POC diagnostic products globally. It has been expected that the number of cellphone users have passed 7.4 billion in emerging countries and the population in the countries is marred by various communicable/non-communicable diseases.

    Furthermore, increasing chronic diseases, rapid upsurge in the aging population, and rising consumer awareness are also positively influencing the POC diagnostic market. Henceforth, Point-of-Care Diagnostics has been predicted to be a revolutionary aid in treatment procedures and projecting emerging countries to be a highly profitable market for POC Diagnostics.

    Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55955/ (Priced at USD 4199)

    The report includes -
    Segmentation: Based on product segment, the POC diagnostic market has been bifurcated and the report displays the market share, growth and revenue of each type:
    • Glucose Monitoring.
    • Cardiometabolic Testing
    • Infectious Disease Testing
    • Coagulation Testing
    • Pregnancy & Fertility Testing
    • Tumor/Cancer Marker Testing
    • Urinalysis Testing
    • Cholesterol Testing
    • Cholesterol Testing
    • Hematology Testing
    • Drugs-of-Abuse Testing
    • Fecal Occult Testing
    • Other

    On the basis on the end-users, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
    • Professional Diagnostic Centers
    • Hospitals
    • Home Care
    • Clinics
    • Others

    Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55955

    Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of POC Diagnostics for these regions, from 2015 to 2025 (forecast)
    • North America: U.S., Rest of North America
    • Europe: Germany, France, UK, rest of Europe
    • Asia Pacific: China, Japan, India and Rest of Asia Pacific
    • Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA
    • Latin America: Brazil and Rest of Latin America


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The Global Tumor Ablation market was valued at USD 750.4 Million in 2015, and is projected to reach USD 2,129 Million by 2025, growing at a CAGR of 11.2% over the forecast period.

    Key players: Overview of market leaders in tumor ablation market by top manufacturers/players, with revenue (Billion USD) and market share for each manufacturer/player. The top players including Covidien, HealthTronics, Galil Medical Inc., Angiodynamics, Misonix Inc., Medtronic Plc., SonaCare Medical, Boston Scientific Corporation, Neuwave Medical Inc. and EDAP TMS S.A. Key players along with certain new entrants in the market, namely-- Covidien, Plc, Medtronic, Inc., SonaCare Medical, LLC and NeuWave Medical, Inc. are investing heavily to strengthen the R&D capabilities for developing the novel tumor ablation products and to expand the clinical application profile of their existing tumor ablation products.

    Get Sample Copy of This Report@ www.qurateresearch.com/report/sample/HnM/QBI-XPR-HnM-55957

    Improved procedural safety profile, technological advancements in the field of healthcare, and increasing number of public-private initiatives is further anticipated to spur the market growth. The demand for minimally invasive surgeries (MIS) is growing with the increasing geriatric population since, patients experience lesser trauma in MIS and recover faster as compared to invasive procedures. Minimally invasive surgeries such as radiofrequency ablations is highly demanded and hence, is responsible for the market growth.

    Furthermore, rising demand of minimal invasive tumor ablation techniques, & funding to support ongoing research activities related to tumor ablation are also responsible for the surge in tumor ablation market. According to the World Health Organization (WHO), about 13% of the people suffer from cancer across the globe. Additionally, it is also estimated that there will be a 70% rise in cancer cases and more than 100 cancer types will require tumor ablation, thereby boosting the market growth over the forecast period.

    Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-XPR-HnM-55957/ (Priced at USD 4199)

    The report includes -
    Segmentation: Based on technology segment, the report segregates the segment and provides the revenue, growth rate, and market share, of each type,
    • Cryoablation
    • Microwave
    • Radiofrequency
    • Other technologies
    o HIFU
    o Radio Iodine
    o Laser Ablation

    On the basis on the treatment, this report focuses on the status and outlook for major applications, market share and growth rate for each application, including
    • Percutaneous Procedures
    • Surgical Procedures
    • Laparoscopic Procedures

    On the basis of application, the market has been segmented further, and displays growth rate and market share over the forecast period;
    • Liver Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Kidney Cancer
    • Bone Metastasis
    • ENT Cancer

    Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-XPR-HnM-55957

    Geographic Segmentation: This report split global market into North America, Europe, Asia Pacific, the Middle East and Africa and Latin America, with revenue (Billion USD), market share and growth rate of tumor ablation market for these regions, from 2015 to 2025 (forecast)
    • North America: U.S., Rest of North America
    • Europe: Germany, France, UK, rest of Europe
    • Asia Pacific: China, Japan, India and Rest of Asia Pacific
    • Middle East & Africa: GCC, North Africa, South Africa and Rest of MEA


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) Factors such as increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies propel the growth of the market. Some of the opportunities for the market are low income countries like India and Africa lacking access to basic healthcare and increasing risk of pandemic and communicable diseases. However, in spite of innovative technologies in the market, developing stable and authentic cell lines remains a major challenge of this market.

    The cell line development market, by type of cell lines is segmented into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. On the basis of source, the market is segmented into mammalians, insects, and amphibians. On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery.

    The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

    Get More Details: https://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html 

    Some of the major players in the global market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC. 
    630 Dundee Road 
    Suite 430 
    Northbrook, IL 60062 
    USA : 1-888-600-6441 
    newsletter@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The report "Healthcare Supply Chain Management Market by Component (Software {Inventory (Order and Warehouse Management), Purchasing (Suppliers, Strategic Sourcing)), Hardware (Barcode, RFID)), Delivery Mode (On-Premise, Cloud), End User - Global Forecasts to 2022", The healthcare supply chain management market is expected to reach USD 2.31 Billion by 2022 from an estimated USD 1.55 Billion in 2017, at a CAGR of 8.4%. The key factors driving the growth of this market include the increased pressure on healthcare providers to improve operational efficiency & profitability, the adoption of the GS1 System of standards in the healthcare industry globally; implementation of the unique device identification initiative by the FDA; emergence of cloud-based solutions; continuous financial support in the form of funding, investments, and partnerships; and the growing efforts to reduce the large-scale counterfeiting of drugs are driving the growth of the market.

    https://www.marketsandmarkets.com/Market-Reports/healthcare-supply-chain-management-market-77439622.html


    By component, the software segment is expected to account for the largest share of the market in 2017

    The healthcare supply chain management market is segmented into software and hardware by component. In 2017, the software segment is estimated to account for the largest share of the healthcare supply chain management market. The large share of the software segment is attributed the various benefits it offers such as increased efficiency, reduced costs, and business.

    The on-premise segment is expected to account for the largest share of the market in 2017

    The market is segmented into on-premise and cloud-based delivery modes. In 2017, on-premise segment is expected to command the largest share of the global healthcare supply chain management market. The large share of this segment can be attributed to its ease of use and the low risk of data breaches.

    Download PDF Brochure :
    https://www.marketsandmarkets.com/pdfdownload.asp?id=77439622

    By end users, the manufacturers segment is expected to account for the largest share of the market in 2017

    The market is segmented into manufacturers, distributors, and providers on the basis of end users. In 2017, manufacturers are expected to be the largest end users of the global healthcare supply chain management market. Manufacturers need supply chain management solutions to better coordinate their transportation and warehouse facilities. These solutions ensure faster, more accurate, and more efficient functioning, and such advantages have increased demand for supply chain management solutions in this segment.

    North America to dominate the market in 2017

    North America is expected to account for the largest share of the global healthcare supply chain management market. The large share of North America can be attributed to factors such as consolidation of hospitals, regulatory requirements, increasing patient burden in the US, and the implementation of various strategies to improve healthcare supply chain management in Canada.

    The prominent players in the global healthcare supply chain management market include SAP (Germany), Oracle (US), Infor (US), GHX (US), McKesson (US), TECSYS (Canada), Manhattan Associates (US), JDA software (US), Jump Technologies (US), and LogiTag (Israel)



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) Foot and ankle devices are used for the treatment of injuries caused by orthopedic disorders, such as diabetic foot, bunions, arthritis, and hammertoes with the help of surgical procedures. These devices also replace the foot lost/ damaged due to amputation, trauma, or congenital conditions. Technological advancements have made these devices lighter and stronger, restricting the additional amount of energy to be applied by the organ; this is driving the market for these devices. This market is expected to reach USD 5.4 Billion by 2020 from USD 3.8 Billion in 2015 at a CAGR of 7.2% during the forecast period.

    The foot and ankle devices market is segmented on the basis of product and cause of injury. The product segments of the market are orthopedic implants and devices, prostheses, and bracing and supporting devices. On the basis of cause of injury, the market is segmented into trauma, diabetes, neurological disorders, and others (osteoporosis, rheumatoid arthritis, osteoarthritis, hammertoe, and bunions). Growth in the number of sports injuries, expected global rise in the prevalence of diabetes, rising prevalence of arthritis in Australia and the U.S., regular entry of new products in the market, and rising geriatric population resulting in the growing incidence of bone injuries are the major factors driving this market. On the other hand, the high cost of some foot and ankle devices and excise tax on medical devices in the U.S. and are expected to restrain the growth of the market. In addition to this, the lack of trained professionals is a major challenge for the global market. However, the introduction of biologics to treat foot and ankle disorders, coupled with expansion & penetration opportunities in BRIC and South Africa, are posing lucrative opportunities for the market.

    Growth in the foot and ankle devices market is likely to be centered on the Asia-Pacific region. This can be attributed to the increasing aging population, increasing number of podiatrists, favorable healthcare systems, and rising awareness through conferences & symposia.

    Get more information: https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html 

    Major players in the global foot and ankle devices market include Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.).

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC. 
    630 Dundee Road 
    Suite 430 
    Northbrook, IL 60062 
    USA : 1-888-600-6441 
    newsletter@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, September 15, 2018 ) The report “North American Healthcare Cloud Computing Market by Application (PACS, RCM, EMR), by Deployment (Private, Public), by Service (SaaS, PaaS), & by End-User (Providers, Payers, Life Sciences) - Analysis & Forecasts to 2020”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    https://www.marketsandmarkets.com/Market-Reports/north-america-healthcare-cloud-computing-market-54089599.html

    This report studies the North American healthcare and life sciences cloud computing market for the forecast period of 2015 to 2020. This market is expected to reach USD 11.43 Billion by 2020 from USD 4.49 Billion in 2015, and is poised to grow at a CAGR of 20.5% during the forecast period.

    The North American healthcare and life sciences cloud computing market is segmented on the basis of application, service model, deployment model, pricing model, component, end-user, and country.

    Based on application, the healthcare and life sciences cloud computing market is categorized into Clinical Information System (CIS), Non-clinical Information System (NCIS), and life sciences applications. In 2015, the Clinical Information System (CIS) segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    On the basis of service model, this market is segmented into software-as-a-service (SaaS), information-as-a-service (IaaS), and platform-as-a-service (PaaS). In 2015, the software-as-a-service (SaaS) segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    Based on deployment model, the market is segmented into private cloud, public cloud, and hybrid cloud. In 2015, the private cloud segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    On the basis of pricing model, this market is segmented into pay-as-you-go and spot pricing. In 2015, the pay-as-you-go segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    Download PDF Brochure:
    https://www.marketsandmarkets.com/pdfdownload.asp?id=54089599

    Based on component model, the market is segmented into hardware, software, and services. In 2015, the software segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    On the basis of end users, the market is segmented into healthcare providers, healthcare payers, and life sciences companies. In 2015, the healthcare providers segment is estimated to account for a major share of the healthcare and life sciences cloud computing market.

    On the basis of country, the market is divided into the U.S. and Canada. In 2015, U.S. is estimated to account for the largest share of the North American healthcare and life sciences cloud computing market and is expected to continue to grow at highest CAGR during the forecast period.

    Over the years, the adoption of cloud computing in healthcare is likely to increase owing to the rising need to curtail healthcare costs and enhance the quality of healthcare, reforms of various countries benefiting healthcare IT, proliferation of new payment models and cost-efficiency of cloud technology, and implementation of the Patient Protection and Affordable Care Act (PPACA) are the major factors driving this market. Moreover, teleCloud and formation of Accountable Care Organizations (ACOs) are to create opportunities for healthcare cloud computing market. However, security of patient data on cloud is a crucial task and is likely to restrain the growth of this market.

    Some of the major players in the North American healthcare and life sciences cloud computing market include athenahealth, Inc. (U.S.), CareCloud Corporation (U.S.), ClearData Networks, Inc. (U.S.), Carestream Health (U.S.), Dell Inc. (U.S.), GNAX Health (U.S.), IBM Corporation (U.S.), Iron Mountain, Inc. (U.S.), Oracle Corporation (U.S.) and VMware, Inc. (U.S.).


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com